Tag: P.C.
Diabetes Drug Risk: W&L Hopes Faster FDA Publication of Potential Risk Signals for SGLT2 Inhibitors
NEWS: (NEW YORK, N.Y.) National lawfirm Weitz and Luxenberg, P.C., said today it hopes potentially fatal side effects associated with SGLT2 inhibitor drugs will be reported to consumers faster, since people taking these next-generation diabetes medications deserve to be notified of the health dangers shortly after they have been reported to the U.S. Food and Drug Administration (FDA).
Weitz and Luxenberg Attorneys are 2016 Super Lawyers ‘Rising Stars’
NEWS: (NEW YORK, N.Y.) Super Lawyers revealed that 8 Weitz and Luxenberg, P.C. attorneys have been named by the magazine as 2016 'Rising Stars' of the profession, Weitz and Luxenberg today announced.
95-percent of Eligible Stryker Hip Patients Now Enrolled in Settlement Program
NEW YORK, N.Y. /eNewsChannels/ -- NEWS: Nationally prominent personal injury law firm Weitz and Luxenberg, P.C., today said that 95 percent of registered eligible patients are now enrolled in the Stryker modular hip settlement program. This program has been established to ensure that each injured patient will receive a share of more than $1 billion as compensation for problems encountered with Rejuvenate and ABGII metal-on-metal modular hip implants.
Weitz & Luxenberg accepting Birth Defect Cases related to Zofran (Ondansetron)
NEW YORK, N.Y. /eNewsChannels/ -- NEWS: Weitz and Luxenberg, P.C., announced it is accepting cases of congenital heart defects and cleft facial abnormalities in children whose mothers took the prescription drug Zofran (GlaxoSmithKline) during pregnancy to relieve symptoms of morning sickness.
Anthem Inc. Customer Data Breach Lawsuit May Help Kids, Too, says Weitz & Luxenberg
LOS ANGELES, Calif. /eNewsChannels/ -- NEWS: The Anthem Inc. (NYSE:ANTM) data breach class action lawsuit brought this month by Weitz and Luxenberg, P.C. seeks to protect tens of millions of children - and not just adults - affected by the health insurance giant's massive loss of sensitive confidential records, the New York-based law firm today announced.
Lenovo Superfish Malware Damage Claims to be Probed by Weitz & Luxenberg
NEW YORK, N.Y. /eNewsChannels/ -- NEWS: A security expert's discovery last month that certain Lenovo laptop computers were shipped with well-concealed malware giving hackers easy access to users' most confidential information has led Weitz and Luxenberg P.C. to announce an investigation into potential legal claims against the hardware manufacturer and against the malware vendor, Superfish, the law firm today disclosed.
$20-Million Verdict against Burnham, LLC for Mesothelioma Victim won by Weitz and Luxenberg
NEW YORK, N.Y. /eNewsChannels/ -- NEWS: The family of a former Navy ship fitter who died earlier this year of mesothelioma received a verdict of $20 million against a manufacturer of boilers that were insulated with asbestos, the law firm of Weitz and Luxenberg P.C. today announced.
Weitz & Luxenberg Files Class Action Lawsuit Against Chrysler
NEW YORK, N.Y. /eNewsChannels/ -- NEWS: *CORRECTION* -- Weitz and Luxenberg on Nov. 13 announced the filing of a class action lawsuit in federal court against Chrysler Group LLC. The nationally respected personal injury and mass tort law firm said it seeks to hold the Big Three automobile maker accountable for economic losses suffered by owners and passengers of Chrysler cars and trucks that stalled, caught fire or sustained other potentially life-endangering malfunctions due to a faulty onboard computer.
Nationally prominent mesothelioma victims champion Perry Weitz to Co-Chair Perrin Conferences Asbestos Symposium
NEW YORK, N.Y. /eNewsChannels/ -- NEWS: Perrin Conferences has selected nationally prominent mesothelioma victims champion Perry Weitz of Weitz and Luxenberg to co-chair its fourth annual asbestos-litigation symposium Dec. 2 at the New York Athletic Club in Manhattan, the law firm today revealed.
Weitz & Luxenberg, P.C., Allied Firms Obtain Stryker Rejuvenate, ABGII Hip Implants Settlement Which Could Top $1 Billion
NEW YORK, N.Y. /eNewsChannels/ -- NEWS: Stryker Corporation (NYSE:SYK) has agreed to pay potentially more than $1 billion to settle claims from patients injured by the company's Rejuvenate and ABGII modular hip implants, the nationally prominent personal-injury law firm of Weitz and Luxenberg, P.C. announced today.
